Abstract
Aged dogs and humans share complex cognitive and pathological responses to aging. Specifically, dogs develop Alzheimers Disease (AD) like beta-amyloid (Aβ) that are associated with cognitive deficits. Currently, therapeutic approaches to prevent AD are targeted towards reduced production, aggregation and increased clearance of Aβ. The current review discusses cognition and neuropathology of the aging canine model and how it has and continues to be useful in further understanding the safety and efficacy of potential AD prevention therapies targeting A
Keywords: Alzheimer's disease, canine, statins, BACE-1 inhibitors, metal-chelators, A-beta vaccination
Current Neuropharmacology
Title: Therapeutic Interventions Targeting Beta Amyloid Pathogenesis in an Aging Dog Model
Volume: 9 Issue: 4
Author(s): Sarah B. Martin, Amy L.S. Dowling and Elizabeth Head
Affiliation:
Keywords: Alzheimer's disease, canine, statins, BACE-1 inhibitors, metal-chelators, A-beta vaccination
Abstract: Aged dogs and humans share complex cognitive and pathological responses to aging. Specifically, dogs develop Alzheimers Disease (AD) like beta-amyloid (Aβ) that are associated with cognitive deficits. Currently, therapeutic approaches to prevent AD are targeted towards reduced production, aggregation and increased clearance of Aβ. The current review discusses cognition and neuropathology of the aging canine model and how it has and continues to be useful in further understanding the safety and efficacy of potential AD prevention therapies targeting A
Export Options
About this article
Cite this article as:
B. Martin Sarah, L.S. Dowling Amy and Head Elizabeth, Therapeutic Interventions Targeting Beta Amyloid Pathogenesis in an Aging Dog Model, Current Neuropharmacology 2011; 9 (4) . https://dx.doi.org/10.2174/157015911798376217
DOI https://dx.doi.org/10.2174/157015911798376217 |
Print ISSN 1570-159X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6190 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
Molecular Docking Study of Catecholamines and [4-(Propan-2-yl) Phenyl]Carbamic acid with Tyrosine Hydroxylase
CNS & Neurological Disorders - Drug Targets Preface (New Research Frontiers and Advances in Drug Addiction)
Current Neuropharmacology Can't Always Get What you Want? Try an Indirect Route you Just Might Get What you Need: A Study on Access to Genetic Data by Canadian Life Insurers
Current Pharmacogenomics and Personalized Medicine Meet the Editorial Board
CNS & Neurological Disorders - Drug Targets Neurohormonal Activation in Ischemic Stroke: Effects of Acute Phase Disturbances on Long-Term Mortality
Current Neurovascular Research Commentary
CNS & Neurological Disorders - Drug Targets Not Just the Brain: Methamphetamine Disrupts Blood-Spinal Cord Barrier and Induces Acute Glial Activation and Structural Damage of Spinal Cord Cells
CNS & Neurological Disorders - Drug Targets Insulin Resistance, Glycemic Control and Adiposity: Key Determinants of Healthy Lifespan
Current Alzheimer Research Drug Therapy for Patients with Eating Disorders
Current Drug Targets - CNS & Neurological Disorders Immune Responses to AAV in Clinical Trials
Current Gene Therapy Elderly Hypertensive Patients: Silent White Matter Lesions, Blood Pressure Variability, Baroreflex Impairment and Cognitive Deterioration
Current Hypertension Reviews Environmental (Lifestyle) Risk Factors for LADA
Current Diabetes Reviews Reading and Writing the Blood-Brain Barrier: Relevance to Therapeutics
Recent Patents on CNS Drug Discovery (Discontinued) Novel High-affinity Aβ-binding Peptides Identified by an Advanced In Vitro Evolution, Progressive Library Method
Protein & Peptide Letters Fetal Alcohol Syndrome: A Cautionary Note
Current Pharmaceutical Design Editorial [Hot Topic: Applications of Angiotensin Converting Enzyme Inhibitors and of Angiotensin II Receptor Blockers in Pharmacology and Therapy: An Update (Executive Editor: Agostino Molteni)]
Current Pharmaceutical Design CNS Immune Surveillance and Neuroinflammation: Endocannabinoids Keep Control
Current Pharmaceutical Design Inhibition of Butyrylcholinesterase with Fluorobenzylcymserine, An Experimental Alzheimer's Drug Candidate: Validation of Enzoinformatics Results by Classical and Innovative Enzyme Kinetic Analyses
CNS & Neurological Disorders - Drug Targets Establishment of Cell-Based Neuroglobin Promoter Reporter Assay for Neuroprotective Compounds Screening
CNS & Neurological Disorders - Drug Targets Metabolomics
Current Drug Metabolism